Other

Unrealized Gain (Loss) on Investments

Amgen Unrealized Gain (Loss) on Investments decreased by 107.3% to -$143.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 111.0%, from $1.30B to -$143.00M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionOther
CategoryMarket Position
SignalHigher is better
VolatilityVolatile
First reportedQ1 2021
Last reportedQ1 2026Apr 30, 2026

How to read this metric

An increase signals favorable market conditions for the company's investment portfolio, while a decrease signals market headwinds.

Detailed definition

This reflects the change in the market value of investment assets that have not yet been sold. It is a non-cash adjustme...

Peer comparison

Highly comparable for insurance and financial firms; peers are similarly exposed to market-to-market fluctuations.

Metric ID: other_unrealized_gain_loss_on_investments

Historical Data

16 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q4 '22Q1 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q3 '25Q1 '26
Value$0.00$0.00$0.00-$211.00M-$111.00M-$14.00M$1.83B$135.00M$261.00M-$515.00M-$401.00M$1.63B-$876.00M$1.30B$1.97B-$143.00M
QoQ Change+47.4%+87.4%>999%-92.6%+93.3%-297.3%+22.1%+507.2%-153.6%+247.8%+52.2%-107.3%
YoY Change+967.3%>999%-128.1%>999%-435.6%+351.5%+20.7%-111.0%
Range-$876.00M$1.97B
Avg YoY Growth+467.3%
Median YoY Growth+186.1%

Frequently Asked Questions

What is Amgen's unrealized gain (loss) on investments?
Amgen (AMGN) reported unrealized gain (loss) on investments of -$143.00M in Q1 2026.
How has Amgen's unrealized gain (loss) on investments changed year-over-year?
Amgen's unrealized gain (loss) on investments decreased by 111.0% year-over-year, from $1.30B to -$143.00M.
What does unrealized gain (loss) on investments mean?
Change in value of investments that the company still owns.